Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG4010 in advanced non-small cell lung cancer
NCT00415818Phase 3Completed
- Sponsor
- Transgene SA
- Start
- Dec 2005
- Primary completion
- Mar 2010
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 4
01
Overview
A Phase 3 trial of TG4010 in non-small cell lung cancer (NSCLC), sponsored by Transgene SA. Started Dec 2005; status: completed.
02
Drugs
TG4010
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00415818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415818.